메뉴 건너뛰기




Volumn 348, Issue , 2014, Pages

Bad medicine: Nalmefene in alcohol misuse

(1)  Spence, Des a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NALMEFENE; NALTREXONE; PLACEBO;

EID: 84896709860     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g1531     Document Type: Note
Times cited : (22)

References (9)
  • 1
    • 84896734814 scopus 로고    scopus 로고
    • Scottish Medicines Consortium. Nalmefene 18 mg film-coated tablets (Selincro®). 2013. www.scottishmedicines.org.uk/files/advice/nalmefene- Selincro-FINAL-September-2013- website.pdf.
    • (2013) Nalmefene 18 Mg Film-coated Tablets (Selincro®)
  • 3
    • 84886798117 scopus 로고    scopus 로고
    • A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence
    • ESENSE 2 Study Group
    • Gual A, ESENSE 2 Study Group. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. Eur Neuropsychopharmacol 2013;23: 1432-42.
    • (2013) Eur Neuropsychopharmacol , vol.23 , pp. 1432-1442
    • Gual, A.1
  • 4
    • 84875713675 scopus 로고    scopus 로고
    • Extending the treatment options in alcohol dependence: A randomized controlled study of as-needed nalmefene
    • Mann K, Bladström A, Torup L, Gual A, van den Brink W. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biol Psychiatry 2013;73: 706-13.
    • (2013) Biol Psychiatry , vol.73 , pp. 706-713
    • Mann, K.1    Bladström, A.2    Torup, L.3    Gual, A.4    Van Den Brink, W.5
  • 5
    • 84896726546 scopus 로고    scopus 로고
    • Safety and efficacy of nalmefene in patients with alcohol dependence (SENSE). http://clinicaltrials.gov/ct2/show/results/NCT00811941?term= Sense+nalmefene&rank=1& sect=Xd8k96015#outcome8.
  • 6
    • 84883015520 scopus 로고    scopus 로고
    • Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: Results from a subgroup analysis of two randomized controlled 6-month studies
    • Van den Brink W, Aubin HJ, Bladström A, Torup L, Gual A, Mann K. Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies. Alcohol Alcohol 2013;48: 570-8.
    • (2013) Alcohol Alcohol , vol.48 , pp. 570-578
    • Van Den Brink, W.1    Aubin, H.J.2    Bladström, A.3    Torup, L.4    Gual, A.5    Mann, K.6
  • 7
    • 84879847571 scopus 로고    scopus 로고
    • How is alcohol consumption affected if we account for under-reporting? A hypothetical scenario
    • Boniface S, Shelton N. How is alcohol consumption affected if we account for under-reporting? A hypothetical scenario. Eur J Public Health 2013;23: 1076-81.
    • (2013) Eur J Public Health , vol.23 , pp. 1076-1081
    • Boniface, S.1    Shelton, N.2
  • 8
    • 84896718737 scopus 로고    scopus 로고
    • Nalmefene. British National Formulary. 2014. www.medicinescomplete.com/ mc/bnf/current/PHP33535-nalmefene.htm.
    • (2014)
  • 9
    • 84896702639 scopus 로고    scopus 로고
    • Naltrexone effective for alcohol dependence
    • McAvoy BR. Naltrexone effective for alcohol dependence. Cochrane Primary Health Care Field 2010. www.cochraneprimarycare.org/pearls/naltrexone-effective- alcohol-dependence.
    • Cochrane Primary Health Care Field 2010
    • McAvoy, B.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.